District Court Grants Summary Judgment and Invalidates Patent in REGENXBIO v. Sarepta Litigation
LexBlog IP
JANUARY 8, 2024
On January 5, 2024, in litigation between REGENXBIO and Sarepta Therapeutics, Judge Richard Andrews of the U.S. A trial was scheduled to begin on January 29, 2024. Sarepta Litigation appeared first on Big Molecule Watch. A separate, related patent lawsuit filed by REGENXBIO and Penn against Sarepta and Catalent, Inc.
Let's personalize your content